S

Smith+Nephew

Global medical devices for orthopedics

Compliance Director - Advanced Wound Management

Full-Time
$143k - $235.1k/yr+ Bonus + Discounted stock options + 401(k) match
Senior
Bachelor's
Remote in USA+6 moreMore locations: Andover, MA, USA | Austin, TX, USA | Memphis, TN, USA | Pittsburgh, PA, USA | Fort Worth, TX, USA | Columbia, MD, USA
HybridThe role is remote or based in one of the listed U.S. offices and involves up to 15% travel.

About the job

Requirements
  • Seven to ten years of progressive healthcare compliance experience, including increasing responsibility for implementing and managing a compliance program within a complex United States healthcare business.
  • Expertise in United States laws and regulations applicable to interactions with healthcare professionals and healthcare organizations, including the Anti-Kickback Statute, False Claims Act, and applicable industry codes.
  • Excellent communication and interpersonal skills, with the ability to communicate complex topics concisely.
  • Ability to lead change and influence in a matrix organization.
  • Ability to communicate concisely and persuasively in writing and draft clear, effective reports and policies.
  • Strong analytical skills and the ability to persuade through positive communication.
  • Ability to work across cultures with all levels of the organization and different functions.
  • Ability to detect risk areas and red flags.
  • Solution-minded approach, with the ability to find innovative solutions and challenge established ways of working.
  • Project management skills and the ability to follow through and complete tasks on time.
Responsibilities
  • Lead implementation of the Global Compliance Program in the Advanced Wound Management business unit in the United States.
  • Develop strategies and action plans to address market- and business-unit-specific risks, drive timely completion of risk mitigation plans, and measure the effectiveness of risk-reduction actions.
  • Monitor market, regional, and global developments and conduct benchmarking to ensure the compliance program represents best practice.
  • Partner with business leaders to measure, establish, and monitor compliance culture in the business unit.
  • Develop and lead implementation of policies and procedures for market-specific compliance activities.
  • Drive local implementation of enhancements to the global compliance program and provide input on potential enhancements.
  • Establish effective local compliance training and communication programs using market-appropriate methods.
  • Develop and implement a risk-based local monitoring program and support Global Compliance Audit and Internal Audit teams with monitoring and auditing.
  • Drive third-party seller and non-seller third-party compliance management and initiatives in the region, including third-party risk assessments and site visits.
  • Partner with business teams to ensure third-party strategies appropriately address compliance risks and develop mitigation plans.
  • Represent Compliance in leadership team meetings.
  • Ensure appropriate and consistent corrective actions are implemented for compliance issues.
  • Monitor and report compliance key performance indicators and create action plans to address performance gaps.
Desired Qualifications
  • Legal background, including a law degree or substantial experience interpreting and applying United States healthcare laws and regulations in a compliance role.
  • Relevant industry experience in one or more of pharmaceuticals, medical devices, pharmacy-related business models, biologics or tissue-based products, and technology-enabled healthcare solutions.

About the company

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
  • New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
  • August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.

What critics are saying

  • Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
  • Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
  • A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.

What makes Smith+Nephew unique

  • Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
  • Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
  • ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Holidays

Flexible Work Hours

Parental Leave

Fertility Treatment Support

Family Planning Benefits

Tuition Reimbursement

Wellness Program

Mental Health Support

Volunteer Time Off

Home Office Stipend

Phone/Internet Stipend

Discounted Stock Options

Health Savings Account/Flexible Spending Account

Employee Assistance Program

PTO/vacation?

Paid Sick Leave

Company News

Kalkine Media
Sep 10th, 2026
Smith+Nephew issues $700M 5.750% bonds due 2036 to refinance 2030 senior notes

Smith & Nephew has issued $700 million in senior notes with a 5.750% coupon maturing in 2036, netting $690.9 million after underwriting fees. The FTSE 100 medical technology firm will primarily use proceeds to fund a tender offer for its existing 2.032% senior notes due 2030, with remaining funds allocated to general corporate purposes. The refinancing replaces lower-yield debt with higher-coupon notes, reflecting current credit market conditions. BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and SMBC Nikko Securities America managed the transaction, which closed on 11 September 2026. Founded in Hull in 1856, Smith & Nephew operates across orthopaedics, sports medicine, ENT, and advanced wound management. The company employs approximately 17,000 people across 100 countries and reported annual sales of $6.2 billion in 2025.

Ticker Report
Sep 3rd, 2026
Corient Private Wealth LP Makes New $2 Million Investment in Smith & Nephew SNATS, Inc. $SNN

Corient Private Wealth LP purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 31,871 shares of the medical equipment provider’s stock, valued at approximately $1,999,000. Other large investors […]

Yahoo Finance
Aug 17th, 2026
Smith+Nephew launches FLOW FLEXTEND COBLATION Wand with adjustable-angle tip for complex hip procedures

Smith+Nephew has launched the FLOW FLEXTEND COBLATION Wand, a new radiofrequency resection device designed for complex hip procedures. The device features an adjustable-angle tip that provides enhanced joint access and tissue targeting in difficult-to-reach hip, knee, and shoulder anatomies. The wand incorporates Smith+Nephew's FLOW~IQ technology, which automatically balances saline outflow with COBLATION energy. Its design includes a precision electrode with an adjustable tip that improves access to targeted tissues whilst facilitating insertion and removal. The angle adjustment mechanism allows surgeons to set the desired position without continuous manual control. Early surgeon feedback has been positive, with users highlighting improved versatility in the central compartment and precise tissue preservation capabilities compared to existing instruments.

Yahoo Finance
Jul 21st, 2026
Smith+Nephew launches ASC Solutions strategy to help ambulatory surgery centres optimise costs and outcomes

Smith+Nephew has launched ASC Solutions, an enterprise strategy designed to help ambulatory surgery centres optimise costs, improve quality and enhance performance. The initiative provides ASCs with access to clinical expertise, procedural technologies and data analytics to support growth and patient outcomes in value-based care settings. The company is expanding its ASC ONE delivery model into an integrated platform that simplifies centre development and accelerates facility readiness. ASC ONE coordinates services including facility design, construction, financing and clinical enablement through a single point of contact. Smith+Nephew has partnered with STERIS Unity Health Centers, Brasfield & Gorrie, Ghafari and Hopper Healthcare to provide expertise across the ASC lifecycle. The model enables physician-led organisations and health systems to streamline vendor management whilst reducing complexity and improving execution timelines.

Yahoo Finance
Jun 8th, 2026
Smith+Nephew completes first clinical cases with CORI XT handheld robotics platform for knee and shoulder surgery

Smith+Nephew has completed the first clinical cases using its next-generation CORI XT Handheld Robotics Platform for knee and shoulder arthroplasty. The platform is designed as a single handheld robotics system for various orthopaedic procedures, including partial to revision knee, hip, and anatomic and reverse shoulder surgeries. The first shoulder arthroplasty cases were performed at Duke Health by Dr Christopher Klifto, who used CORI SHOULDER Handheld Robotic Arthroplasty with the AETOS Shoulder System. Dr Bertrand Kaper subsequently completed the first CORI XT shoulder cases in an ambulatory surgery centre setting in Scottsdale, Arizona. The platform supports both hospital and ambulatory surgical centre environments, with a compact footprint tailored to different facility needs. Smith+Nephew's approach aims to enhance surgeon expertise whilst maintaining clinical control and workflow efficiency.